In Vivo Models for Golgi Fragmentation and the Molecular Pathogenesis of Alzheimer’s Disease

Developing Cell-Type-Specific Enhancer-AAV Vectors to Characterize and Restore Amyloid Beta- and Tau-Dependent Circuit and Cognitive Deficits in Humanized Alzheimer’s Mouse Models Jorge Palop 2025-02-24 Protection Against Alzheimer’s Disease with Longevity-Promoting Intervention 17a-Estradiol Christian Pike Bérénice A. Benayoun 2024-12-23 Alzheimer’s Disease PET Imaging of Nonfibrillar Amyloid Beta Aggregates Using Azapeptide (AZP) Tracer Sam Gandy Brigitte Guérin Shai Rahimipour William Lubell 2024-12-16 Identifying Age-Related Proteomic Changes That Predict Future Onset of Amyloid Beta Aggregation in Late-Onset Alzheimer’s Disease Randall J. Bateman 2024-12-16 Evaluating the Contribution of TDP-43 Dysfunction and Cryptic Mis-Splicing to Alzheimer’s Disease Pathogenesis Leonard Petrucelli 2024-10-31 Role of Psychosocial Stress in Alzheimer’s Disease Filip Swirski 2024-10-31 Pre-Clinical Testing of CDK4/6 Inhibitors as a Therapeutic Strategy in Alzheimer’s Disease Using Alzheimer’s Disease Tauopathy Mouse Model Peter Sicinski 2024-09-24 Dysregulation of Signaling on Post Synaptic Density Scaffolds in Alzheimer’s Disease Alexandra C. Newton 2024-07-29